Louis Mourier Hospital
Colombes, 92700, France
NCT Number: NCT02528734
Monocentric observational study of needle exsufflation for pneumothorax in the ICU.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Colombes, 92700, France
The main objective of this prospective observational non interventional study is to investigate a possible relationship between prior duration of pneumothorax (defined as the duration from first occurence of chest pain reported by patient to exsufflation) and the success of exsufflation procedure (defined by the absence of a chest tube insertion in the following 24h).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 24 hrs
success of needle exsufflation is defined as the absence of chest tube insertion requirement within 24hrs following needle exsufflation
Time frame: 24 hrs
success of needle exsufflation is defined as the absence of chest tube insertion requirement within 24hrs following needle exsufflation; duration of symptoms prior to exsufflation is the time (in hrs) elapsed between first chest pain reported by the patient and needle exsufflation
Time frame: 8 days
participants will be followed for the duration of ICU stay, from ICU admission to ICU discharge, an expected average of 8 days
Time frame: 15 days
participants will be followed for the duration of hospital stay, from hospital admission to hospital discharge, an expected average of 15 days
Time frame: 8 days
Patients will be monitored for eventual need for surgical pleurodesis during their ICU stay because of persistent or worsening pneumothorax
Time frame: 8 days
late exsufflation failure is defined as patients requiring chest tube insertion at least 24 hrs after needle exsufflation because of persistent or worsening of pneumothorax despite initial early success
Time frame: 30 days
Patients will be followed for an expected average of 30 days to identify those with recurrent pneumothorax
Time frame: 30 mintutes
patients are asked to assess the maximal pain felt during needle exsufflation or chest tube insertion with the use of a numeric scale from 0 [no pain] to 10 [worst possible pain]
Time frame: 8 days
Patients will be followed for 8 days to identify those with either hemothorax (defined as hematic pleural effusion requiring thoracic drainage); or a vacuo pulmonary edema (defined as occurrence of localised alveolar interstitial opacities on post-procedure chest X-ray); or site of chest tube insertion infection (presence of purulent secretions issuing from chest tube insertion site)
Hôpital Louis Mourier
Other
Impact of Pneumothorax Duration Before Treatment on the Success of Needle Exsufflation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05963945
Atelectasis, Cardiomegaly
Havířov, Czechia
View Trial DetailsNCT03098524
Atelectasis, Bleeding
Neuilly-sur-Seine, Île-de-France Region, France
View Trial DetailsNCT06075836
Atelectasis, Bronchial Diseases
Oxford, Oxfordshire, United Kingdom
View Trial DetailsNCT04630301
Pleural Diseases, Pneumothorax
Baltimore, Maryland, United States
View Trial Details